GMF-1A3-MMAE (Gundersen Medical Foundation)

N/A

Report date: 2025/06/11 10:54:56

Base Information

Drug NameGMF-1A3-MMAE (Gundersen Medical Foundation)
Drug Alias Nameantibody drug conjugate targeting amphiregulin neo-epitope (Gundersen Medical Foundation)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate
Mechanisms of ActionAmphiregulin modulatorsMicrotubule inhibitors
TargetsAmphiregulin
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGundersen Health System
China Registration ClassN/A

Develop Information

Active CompaniesGundersen Health System
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A